AstraZeneca vaccine benefits 'outweigh' risk of blood clots, say health officials

AstraZeneca vaccine benefits 'outweigh' risk of blood clots, say health officials

File picture: PA

The Health Products Regulatory Authority (HPRA) has been notified of approximately 2,800 reports of suspected side effects associated with the AstraZeneca vaccine.

In a statement, the HPRA said that of 204,270 Astrazeneca doses administered, there were 18 reports describing "blood clots or events possibly associated with blood clots."

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited